HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Osamu Nakanishi Selected Research

Overactive Urinary Bladder (Overactive Bladder)

1/2020KPR-5714, a Novel Transient Receptor Potential Melastatin 8 Antagonist, Improves Overactive Bladder via Inhibition of Bladder Afferent Hyperactivity in Rats.
1/2017Synthesis and optimization of novel α-phenylglycinamides as selective TRPM8 antagonists.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Osamu Nakanishi Research Topics

Disease

4Neoplasms (Cancer)
10/2013 - 05/2005
2Pain (Aches)
01/2021 - 11/2009
2Overactive Urinary Bladder (Overactive Bladder)
01/2020 - 01/2017
2Breast Neoplasms (Breast Cancer)
11/2016 - 02/2002
2Trigeminal Neuralgia (Tic Douloureux)
01/2014 - 11/2009
2Prostatic Neoplasms (Prostate Cancer)
10/2013 - 06/2005
2Hyperalgesia
05/2012 - 04/2003
1Cerebral Infarction
05/2021
1Interstitial Cystitis (Interstitial Cystitis, Chronic)
01/2017
1Hypotension (Low Blood Pressure)
01/2017
1Squamous Cell Carcinoma of Head and Neck
09/2012
1Carcinoma (Carcinomatosis)
06/2005
1Renal Cell Carcinoma (Grawitz Tumor)
05/2005
1Experimental Melanoma
04/2002
1Colorectal Neoplasms (Colorectal Cancer)
04/2002

Drug/Important Bio-Agent (IBA)

3entinostat (MS 275)IBA
06/2005 - 02/2002
2benzamideIBA
01/2020 - 01/2017
2Carbamazepine (Tegretol)FDA LinkGeneric
01/2014 - 11/2009
2Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
06/2005 - 05/2005
2Histone Deacetylase InhibitorsIBA
06/2005 - 05/2005
1mirabegronIBA
05/2021
1Ion Channels (Ion Channel)IBA
01/2021
1Estrogens (Estrogen)FDA Link
11/2016
1Estrogen Receptor betaIBA
11/2016
1Local AnestheticsIBA
01/2014
1Tetracaine (Amethocaine)FDA LinkGeneric
01/2014
1AndrogensIBA
10/2013
1TAK-441IBA
10/2013
1LigandsIBA
10/2013
1Peptide Hydrolases (Proteases)FDA Link
09/2012
1Serine (L-Serine)FDA Link
09/2012
1propentofyllineIBA
05/2012
1Drug CombinationsIBA
06/2005
1RetinoidsIBA
06/2005
1LuciferasesIBA
06/2005
1Glutamic Acid (Glutamate)FDA Link
04/2003
1Adenosine A1 ReceptorIBA
04/2003
1Formaldehyde (Formol)FDA Link
04/2003
1N-(1-methyl-2-phenylethyl)adenosine (S-PIA)IBA
04/2003
1Paclitaxel (Taxol)FDA LinkGeneric
04/2002
1dofequidar (MS 209)IBA
04/2002
1Transforming Growth Factor-beta Type II ReceptorIBA
02/2002
1Histone Acetyltransferases (Histone Acetyltransferase)IBA
02/2002
1Histone Deacetylases (Histone Deacetylase)IBA
02/2002
1Transforming Growth Factor beta (TGF-beta)IBA
02/2002

Therapy/Procedure

1Castration
10/2013
1Therapeutics
06/2005
1Analgesia
04/2003